Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

Mise à jour : Il y a 5 ans
Référence : NCT01203631

Femme et Homme

Extrait

This trial is conducted in Europe and North America. The aim of the trial is to assess disease activity and safety in subjects with moderately to severely active Crohn's disease (CD) when treated with NNC 0142-0000-0002.


Critère d'inclusion

  • Inflammation ,Crohn’s Disease


Liens